StockNews.com Initiates Coverage on Compugen (NASDAQ:CGEN)
Investment analysts at StockNews.com initiated coverage on shares of Compugen (NASDAQ:CGEN – Get Rating) in a note issued to investors on Thursday. The firm set a “hold” rating on the biotechnology company’s stock. Several other research analysts have also commented on CGEN. SVB Leerink restated an “outperform” rating on shares of Compugen in a research […]